T he biotech and pharmaceutical sectors stand at the brink of innovation and strategic transformation. Market momentum continues to build, with the global biotechnology market valued at around $2 ...

IBT's Ailsa Craig and Marek Poszepczynski give their key stock picks as companies move on from the science to commercial ...

Delray Beach, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) -- According to a research report published by MarketsandMarkets, the global agriculture biotechnology market is set to surge from USD 92.19 billion in ...

Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.

John F. Crowley is president and CEO of the Biotechnology Innovation Organization. Kendalle Burlin O’Connell is CEO and president of MassBio. As nearly 20,000 scientists, executives, investors, ...

Massachusetts’ biotech workforce remained relatively stagnant last year, following several years of slowing growth, according to data released Tuesday by MassBioEd, an industry group focused on ...

Over the past couple of years, the integration of Artificial Intelligence (AI) has ignited a revolutionary shift within the biotechnology industry. By mining massive biological datasets, AI has been ...

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...

The expanded team brings decades of experience spanning biotechnology, AI, and commercialization–advancing Salt AI’s mission to help translational scientists and drug developers accelerate discovery ...

On March 30, 2026, Viva Biotech Holdings ("Viva Biotech", "the Group" or "the Company", stock code: 1873.HK) announced that for the Group's revenue amounted to RMB1,729.4 million during the Reporting ...